Quick Links

Steering Committee

Clinical Research Ethics Consultation Collaborative

Steering Committee

The CREC Collaborative Steering Committee members are Benjamin Wilfond and Holly Taylor (Co-Chairs), Mildred Cho, Marion Danis, Liza-Marie Johnson, and Kathryn Porter (Collaborative Coordinator).

The Steering Committee meets on the third Wednesday of each month.

Benjamin S. Wilfond, MD, Co-Chair

Benjamin S. Wilfond, MD is Professor and Chief of the Division of Bioethics in the Department of Pediatrics at the University of Washington School of Medicine and the Director of the Treuman Katz Center for Pediatric Bioethics at Seattle Children’s Research Institute. Dr. Wilfond is the Chief of the Bioethics Consultation Service and a pediatric pulmonologist at Seattle Children’s Hospital. He coordinates the Research Bioethics Consult Service for the Institute of Translational Health Sciences. Dr. Wilfond is the former chair of the intramural NHGRI IRB and has 25 years of experience on IRBs and DMCs. His current scholarship focuses on ethical and policy issues related to genetic testing, pediatrics, and clinical research.

Holly A. Taylor, PhD, MPH, Co-Chair

Holly A. Taylor, PhD, MPH is Associate Professor in the Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, and a core faculty member of the Johns Hopkins Berman Institute of Bioethics. She is currently the Director of the Research Ethics Consulting Service at Johns Hopkins, serving faculty in the Schools of Public Health, Medicine, and Nursing. Dr. Taylor has expertise in public health research, researchers’ obligation to their research subjects, informed consent, recruitment into clinical trials, research oversight, and has experience with quantitative and qualitative research methodology.

Mildred Cho, PhD

Mildred Cho, PhD is Professor of Pediatrics at Stanford University, Associate Director of the Stanford Center for Biomedical Ethics, and Director of the Center for Integration of Research on Genetics and Ethics (an NIH-supported Center for Excellence in Ethical, Legal and Social Implications Research). She is also Director of Stanford’s Benchside Ethics Consultation Service. Dr. Cho’s major areas of interest are the ethical and social impacts of genetic research and its applications, and how conflicts of interest affect the conduct of academic biomedical research. Her current research projects examine ethical and social issues in research on prenatal genetic testing, the human microbiome, and synthetic biology, and the ethics of clinical and translational research.

Marion Danis, MD

Marion Danis, MD is Head of the Section on Ethics and Health Policy in the Department of Bioethics at the National Institutes of Health Clinical Center. She also serves as Chief of the Ethics Consultation Service. Dr. Danis has studied patients’ treatment preferences at the end of life and the effectiveness of advance directives in promoting their preferences as well as strategies for fair rationing of limited health care resources and strategies to address the social determinants of health to reduce health disparities. As Chief of the Bioethics Consultation Service she has been the lead editor of the volume published by Oxford University Press entitled Research Ethics Consultation: A Casebook. She has chaired the International Society on Priorities in Health Care and has served on the board of American Society for Bioethics and Humanities.

Liza-Marie Johnson, MD, MPH, MSB

Liza-Marie Johnson, MD, MPH, MSB is a pediatric oncology hospitalist and bioethicist at St. Jude Children’s Research Hospital in Memphis, TN. She is Chair of the Hospital Ethics Committee and a member of the St. Jude Institutional Review Board. Dr. Johnson conducts clinical and research ethics consultations at St. Jude and is actively engaged in clinical research. Her research interests are focused in pediatric ethics as well as quality-­‐of-­‐life concerns in the context of pediatric cancer. Dr. Johnson is particularly interested in improving communication and decision-­‐making in the context of early phase clinical research trials or in research involving advanced genomic sequencing technologies.

Kathryn M. Porter, JD, MPH - Collaborative Coordinator

Kathryn M. Porter, JD, MPH is a Research Associate for the Treuman Katz Center for Pediatric Bioethics at Seattle Children’s Research Institute and a research ethics consultant for the Institute of Translational Health Sciences. She also serves as the Coordinator for the CREC Collaborative. Her interests include research ethics and the ethical and legal issues related to genetics.